GURU.Markets stock price, segment price, and overall market index valuation
The company's share price Bio Rad Laboratories
Bio-Rad Laboratories is a manufacturer of instruments and reagents for scientific research and clinical diagnostics. Its share price reflects stable R&D spending in the life sciences, as well as its significant stake in Sartorius, a significant value driver.
Share prices of companies in the market segment - Medanalysis
Bio-Rad Laboratories operates in the scientific research and clinical diagnostics segments. We classify it as part of the Medical Analysis sector. The chart below shows the dynamics of this stable segment, which is driven by R&D and healthcare spending.
Broad Market Index - GURU.Markets
Bio-Rad Laboratories is a global leader in the production of instruments and reagents for scientific research and clinical diagnostics. Its stable business and reputation have earned it a place in the GURU.Markets index. The chart below shows how the company's shares perform against the broader market.
Change in the price of a company, segment, and market as a whole per day
BIO - Daily change in the company's share price Bio Rad Laboratories
For Bio-Rad Laboratories, a supplier of life science equipment, daily price change is a measure of volatility associated with science and healthcare funding. This metric serves as an important component in complex formulas on System.GURU.Markets that evaluate the dynamics of the Life Science sector.
Daily change in the price of a set of shares in a market segment - Medanalysis
Bio-Rad Laboratories, Inc. is a diversified manufacturer of life sciences and diagnostics products. This chart shows the average daily volatility of the sector. Comparing it to BIO's performance helps assess whether its broad portfolio makes it more or less stable than its more specialized peers.
Daily change in the price of a broad market stock, index - GURU.Markets
Bio-Rad Laboratories is a manufacturer of instruments and reagents for biomedical research and clinical diagnostics. Its business serves as a barometer of global scientific activity. The chart below shows general market fluctuations, which can be used to assess Bio-Rad's stability.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization Bio Rad Laboratories
Bio-Rad is a life sciences company providing diagnostic and research tools and solutions. Its year-over-year performance reflects the level of global R&D investment in pharmaceuticals and biotechnology. The chart below tells the story of its role in the scientific world.
Annual dynamics of market capitalization of the market segment - Medanalysis
Bio-Rad Laboratories, Inc. is a manufacturer of a wide range of instruments and consumables for scientific research and clinical diagnostics. Its diversified portfolio provides stability. The chart shows how its key role in the life sciences ecosystem influences its robust growth.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
Bio-Rad Laboratories supplies equipment and reagents for scientific research and medical diagnostics. It is a stable, non-cyclical business driven by consistent R&D spending. The company's stock often appears like a safe haven, demonstrating steady growth unaffected by the volatility of consumer and industrial sectors.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization Bio Rad Laboratories
Bio-Rad, a manufacturer of instruments and reagents for biomedical research, depends on its R&D budgets for its performance. The monthly fluctuations on the chart reflect stable demand from scientific laboratories and the diagnostics sector, which is less susceptible to short-term economic cycles.
Monthly dynamics of market capitalization of the market segment - Medanalysis
This chart reflects the dynamics of the life sciences sector. For Bio-Rad, a leading manufacturer of instruments and reagents, this provides context. Its movements reflect R&D spending by pharmaceutical and biotech companies.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
Bio-Rad Laboratories is a manufacturer and supplier of a wide range of products and services for biomedical research and clinical diagnostics. The chart below shows overall market sentiment. Bio-Rad's performance is driven by global spending on science and healthcare, which gives its shares relative stability.
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization Bio Rad Laboratories
Shares of Bio-Rad Laboratories, a supplier of life science products, reflect news from the world of science and medicine. Weekly fluctuations reflect reactions to new discoveries, changes in R&D funding, and demand from pharmaceutical and diagnostic companies.
Weekly dynamics of market capitalization of the market segment - Medanalysis
Bio-Rad Laboratories, as a supplier to biomedical research, reflects general trends in scientific funding. Pharmaceutical companies' R&D budgets and government grants create a common demand for all players. The chart shows whether BIO is moving in lockstep with the industry or whether its diagnostics segment is driving its own momentum.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
Bio-Rad Laboratories, as a healthcare company, can demonstrate defensive qualities. Demand for its diagnostic and research products is weakly dependent on the economic outlook, which may make its shares more stable than the overall market. The chart will help assess whether BIO truly is a safe haven during periods of general market turbulence.
Market capitalization of the company, segment and market as a whole
BIO - Market capitalization of the company Bio Rad Laboratories
Bio-Rad Laboratories' stock price reflects its investment in scientific research and clinical diagnostics. Its performance reflects how the financial world views the demand for gene and protein analysis tools and reagents. Its movements tell the story of how science and medicine are becoming increasingly precise and personalized.
BIO - Share of the company's market capitalization Bio Rad Laboratories within the market segment - Medanalysis
Bio-Rad Laboratories is a manufacturer of instruments and reagents for biomedical research and clinical diagnostics. Its share of its segment's market capitalization reflects its strong market position and broad customer base. The chart below demonstrates the stability of its business, supported by consistent demand from the scientific and medical sectors.
Market capitalization of the market segment - Medanalysis
Bio-Rad Laboratories supplies instruments and reagents for biomedical research and clinical diagnostics. The chart below shows the total value of the medical analysis sector. This represents the market capitalization of the industry that enables drug discovery and accurate diagnostics.
Market capitalization of all companies included in a broad market index - GURU.Markets
Bio-Rad Laboratories supplies instruments and reagents for biomedical research and clinical diagnostics. The company's market capitalization reflects its fundamental role in science and medicine. On an economic scale, its value reflects the weight of the technologies that enable scientists to study life at the cellular level and doctors to make accurate diagnoses.
Book value capitalization of the company, segment and market as a whole
BIO - Book value capitalization of the company Bio Rad Laboratories
Bio-Rad Laboratories' book value is a scientific and manufacturing base for biomedical research. It consists of factories producing equipment and reagents for diagnostics and scientific discoveries, as well as a global distribution network. The chart below shows how the company has grown its material foundation while serving hospitals and laboratories worldwide.
BIO - Share of the company's book capitalization Bio Rad Laboratories within the market segment - Medanalysis
Bio-Rad Laboratories creates research instruments and reagents in its laboratories and manufacturing facilities. This scientific and industrial infrastructure is its main asset. The chart shows the share of physical assets Bio-Rad controls in the medical analysis sector.
Market segment balance sheet capitalization - Medanalysis
The chart shows the total book value of the life sciences sector. Against this backdrop, Bio-Rad Laboratories appears to be a diversified and capital-intensive player. Producing a wide range of instruments and reagents for research and diagnostics requires ownership of a global network of factories and R&D centers.
Book value of all companies included in the broad market index - GURU.Markets
Bio-Rad Laboratories owns factories and research centers that produce instruments and reagents for biological research and medical diagnostics. The company's balance sheet represents the value of the physical infrastructure that underpins modern life science. The graph below shows the entire material world, and Bio-Rad creates "microscopes" and "test tubes" for it.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - Bio Rad Laboratories
Bio-Rad's balance sheet is the value of its factories and laboratories producing scientific equipment and reagents. Its market valuation also reflects its reputation, built over decades. The MvsBCap_Co chart shows the premium investors are paying for a stable and respected business that is the "shovel supplier" in the biotech gold rush.
Market to book capitalization ratio in a market segment - Medanalysis
Bio-Rad Laboratories supplies instruments and reagents for biomedical research. The chart shows how the market values its scientific foundation and patent portfolio. Its high valuation relative to physical assets reflects investor expectations for its role in the development of diagnostics and scientific discoveries.
Market to book capitalization ratio for the market as a whole
Bio-Rad Laboratories develops and manufactures a wide range of instruments and reagents for biomedical research and clinical diagnostics. The company's value is determined by its technologies and intellectual property. This chart illustrates why research-intensive companies are often valued significantly above their book value, unlike many other sectors.
Debts of the company, segment and market as a whole
BIO - Company debts Bio Rad Laboratories
Bio-Rad Laboratories, a manufacturer of equipment and reagents for biomedical research, uses its debt strategy to support innovation. This chart illustrates how the company raises capital to fund R&D and strategic acquisitions. In a knowledge-intensive industry, debt allows the company to remain at the forefront of science and technology.
Market segment debts - Medanalysis
Bio-Rad Laboratories supplies instruments and reagents for biomedical research and clinical diagnostics. This is a knowledge-intensive industry where leadership is maintained through continuous innovation and, occasionally, strategic acquisitions. This chart provides insight into the company's financial strategy and its approach to funding long-term growth.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio Bio Rad Laboratories
Bio-Rad Laboratories supplies instruments and reagents for biomedical research and clinical diagnostics. This chart shows how the company finances its operations in a mature and stable market. The debt level reflects the balance between R&D investments to maintain competitiveness and capital return programs for shareholders.
Market segment debt to market segment book capitalization - Medanalysis
Bio-Rad Laboratories supplies instruments and reagents for biomedical research and clinical diagnostics. This chart shows the debt dynamics in the medical analytics sector. It allows investors to assess how Bio-Rad uses debt to fund R&D and acquisitions to maintain its leadership in this technologically advanced industry.
Debt to book value of all companies in the market
Bio-Rad Laboratories, a life sciences provider, operates in an innovative market. The chart shows the overall debt levels of all companies. It helps understand how Bio-Rad's growth strategy, including acquisitions, depends on overall capital availability, or whether it is driven primarily by scientific breakthroughs and customer needs.
P/E of the company, segment and market as a whole
P/E - Bio Rad Laboratories
This chart for Bio-Rad Laboratories, a provider of life sciences and clinical diagnostics products, reflects the stability of the healthcare sector. Its moderate P/E ratio is supported by a broad customer base and a diversified product portfolio. Growth may be driven by the launch of new diagnostic tests, while declines may reflect reduced research budgets.
P/E of the market segment - Medanalysis
This chart shows the average P/E ratio for the life sciences research and analytics sector. For Bio-Rad Laboratories, this is an important benchmark. Its P/E ratio, which is in line with the industry average, reflects its position as a stable, diversified company in a mature market, not promising explosive growth but also not carrying high risks.
P/E of the market as a whole
Bio-Rad Laboratories supplies instruments and reagents for biomedical research and clinical diagnostics. The company has a diversified portfolio and a broad customer base, providing stability. This chart compares Bio-Rad's valuation to the overall market and provides insight into how much investors are willing to pay for predictability in the healthcare sector.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company Bio Rad Laboratories
Bio-Rad Laboratories supplies instruments and reagents for biomedical research and clinical diagnostics. The company's future growth depends on research funding and the introduction of new diagnostic tests in hospitals. This graph reflects market expectations regarding stable demand from scientific laboratories and the development of personalized medicine, where Bio-Rad plays a key role.
%20P%2FE%20Bio%20Rad%20Laboratories&width=1500&height=450&colorIndex=35&filename=GURU_Markets_-_Chart-of-the-companys-future-projected-PE-Bio-Rad-Laboratories&v=1772576371756 "Chart of the company's future (projected) P/E Bio Rad Laboratories")
Future (projected) P/E of the market segment - Medanalysis
Bio-Rad Laboratories supplies instruments and consumables for biomedical research and clinical diagnostics. The company serves scientists and physicians worldwide. The data presented reflects industry average expectations, providing insight into how analysts assess Bio-Rad's scientific potential and commercial prospects compared to its competitors.
%20P%2FE%20graph%20of%20the%20market%20segment%20-%20Medanalysis&width=1500&height=450&colorIndex=36&filename=GURU_Markets_-_Future-projected-PE-graph-of-the-market-segment-Medanalysis&v=1772576371770 "Future (projected) P/E graph of the market segment - Medanalysis")
Future (projected) P/E of the market as a whole
Bio-Rad Laboratories supplies instruments and reagents for biomedical research and clinical diagnostics. Their success depends on funding for science and healthcare. This graph of overall expectations demonstrates investor confidence in progress. High optimism is driving increased investment in R&D, ensuring Bio-Rad has stable demand from laboratories working on new treatments.
%20P%2FE%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=37&filename=GURU_Markets_-_Chart-of-the-future-projected-PE-of-the-market-as-a-whole&v=1772576371817 "Chart of the future (projected) P/E of the market as a whole")
Profit of the company, segment and market as a whole
Company profit Bio Rad Laboratories
Bio-Rad Laboratories supplies instruments and reagents for biomedical research and clinical diagnostics. This chart demonstrates financial results based on scientific progress. The company's profits are generated by consistent demand from laboratories, hospitals, and biotech companies, and its growth is fueled by innovation in diagnostics.
Profit of companies in the market segment - Medanalysis
Bio-Rad Laboratories produces instruments and reagents for biomedical research and clinical diagnostics. The company's success depends on funding for science and healthcare spending. This chart shows the overall profitability of the sector, which is supported by the ongoing demand from laboratories and hospitals for accurate and reliable diagnostic analytical systems.
Overall market profit
Bio-Rad Laboratories supplies instruments and reagents for biomedical research and clinical diagnostics. The company's business is supported by stable government and corporate spending on science and healthcare. This provides the company with resilience during periods of economic instability, making it stand out from the overall market dynamics illustrated here.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company Bio Rad Laboratories
Bio-Rad Laboratories supplies instruments and reagents for biomedical research and clinical diagnostics. The company's expected revenue depends on research funding, pharmaceutical activity, and laboratory testing volumes. This chart represents an analyst forecast that takes into account R&D trends and demand for diagnostic solutions in the healthcare system.
%20profit%20of%20the%20company%20Bio%20Rad%20Laboratories&width=1500&height=450&colorIndex=41&filename=GURU_Markets_-_Graph-of-future-projected-profit-of-the-company-Bio-Rad-Laboratories&v=1772576372192 "Graph of future (projected) profit of the company Bio Rad Laboratories")
Future (predicted) profit of companies in the market segment - Medanalysis
Bio-Rad Laboratories provides tools and services for scientific research and clinical diagnostics. The company's products are used to study life at the molecular level. This chart shows profitability forecasts for the life sciences sector. It helps assess how actively research is funded and how this translates into revenue for these providers.
%20profits%20of%20companies%20in%20a%20market%20segment%20-%20Medanalysis&width=1500&height=450&colorIndex=42&filename=GURU_Markets_-_Graph-of-future-predicted-profits-of-companies-in-a-market-segment-Medanalysis&v=1772576372380 "Graph of future (predicted) profits of companies in a market segment - Medanalysis")
Future (predicted) profit of the market as a whole
Bio-Rad Laboratories is a supplier of instruments and reagents for biomedical research and clinical diagnostics. The profit expectations shown in this chart reflect the overall investment climate. Economic growth allows governments and corporations to increase spending on scientific research and healthcare, which directly creates demand for Bio-Rad products in laboratories worldwide.
%20profits%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=43&filename=GURU_Markets_-_Chart-of-future-predicted-profits-of-the-market-as-a-whole&v=1772576372423 "Chart of future (predicted) profits of the market as a whole")
P/S of the company, segment and market as a whole
P/S - Bio Rad Laboratories
Bio-Rad Laboratories supplies instruments and reagents for biomedical research and clinical diagnostics. It is a stable business, supported by ongoing research and healthcare spending. The chart illustrates the market's valuation of the company's revenue, reflecting confidence in its broad product portfolio and long-term prospects in the life sciences industry.
P/S market segment - Medanalysis
Bio-Rad Laboratories is a global leader in the development, production, and sale of a wide range of products for biomedical research and clinical diagnostics. The company's instruments and reagents are used to separate and analyze complex chemical mixtures. This chart shows the average rating for the sector, helping to understand how the market values Bio-Rad's role in science and medicine.
P/S of the market as a whole
Bio-Rad Laboratories produces instruments and reagents for biomedical research and clinical diagnostics. The company serves both scientific laboratories and hospitals. This chart illustrates how the market averages value its revenue and provides insight into the premium investors are willing to pay for earnings in the stable and high-tech healthcare sector.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company Bio Rad Laboratories
Bio-Rad Laboratories develops and manufactures a wide range of instruments and reagents for biomedical research and clinical diagnostics. This chart reflects the market's perception of the company's future revenue. It shows investor expectations for research and diagnostics spending, which drive Bio-Rad's sales.
%20P%2FS%20Bio%20Rad%20Laboratories&width=1500&height=450&colorIndex=47&filename=GURU_Markets_-_The-graph-of-the-companys-future-projected-PS-Bio-Rad-Laboratories&v=1772576372713 "The graph of the company's future (projected) P/S Bio Rad Laboratories")
Future (projected) P/S of the market segment - Medanalysis
Bio-Rad Laboratories supplies a wide range of instruments and reagents for biomedical research and clinical diagnostics. This chart compares market expectations for the company's future sales with industry forecasts. It helps assess how investors view Bio-Rad's growth prospects amid robust demand from the scientific and healthcare sectors.
%20P%2FS%20market%20segment%20graph%20-%20Medanalysis&width=1500&height=450&colorIndex=48&filename=GURU_Markets_-_Future-projected-PS-market-segment-graph-Medanalysis&v=1772576372784 "Future (projected) P/S market segment graph - Medanalysis")
Future (projected) P/S of the market as a whole
This chart reflects investor confidence in the development of life sciences. Bio-Rad Laboratories, supplying instruments and services for biological research and clinical diagnostics, is an integral part of this process. Their sales growth demonstrates that pharmaceutical companies and scientific laboratories are actively investing in the development of new drugs and tests, which is a driver of future growth.
%20P%2FS%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=49&filename=GURU_Markets_-_Chart-of-the-future-projected-PS-of-the-market-as-a-whole&v=1772576372940 "Chart of the future (projected) P/S of the market as a whole")
Sales of the company, segment and market as a whole
Company sales Bio Rad Laboratories
Bio-Rad Laboratories supplies a wide range of products for biomedical research and clinical diagnostics. The company's revenue is diversified through sales of thousands of products, from reagents to sophisticated equipment, to scientific and medical institutions. This chart reflects its global investment in scientific research and healthcare development.
Sales of companies in the market segment - Medanalysis
Bio-Rad Laboratories develops, manufactures, and markets a wide range of products for biomedical research and clinical diagnostics. This chart shows total revenue in the medical analytics sector. It reflects global investments in research and healthcare, which are the primary growth drivers for Bio-Rad's diversified business.
Overall market sales
Bio-Rad Laboratories produces a wide range of instruments and reagents for biomedical research and clinical diagnostics. The company's products are used in laboratories worldwide. Demand is driven by funding for science and healthcare. This overall economic growth chart indirectly reflects the size of budgets allocated for research and diagnostics, which is important to Bio-Rad.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company Bio Rad Laboratories
Bio-Rad Laboratories supplies instruments and reagents for biomedical research and clinical diagnostics. The company's success depends on funding for science and healthcare spending. This chart represents a consolidated analyst revenue forecast, reflecting their outlook for the global life science and diagnostics markets.
%20sales%20of%20the%20company%20Bio%20Rad%20Laboratories&width=1500&height=450&colorIndex=53&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-the-company-Bio-Rad-Laboratories&v=1772576373318 "Schedule of future (projected) sales of the company Bio Rad Laboratories")
Future (projected) sales of companies in the market segment - Medanalysis
Bio-Rad Laboratories produces a wide range of instruments and reagents for biomedical research and clinical diagnostics. The company's success depends on the level of scientific funding and healthcare spending worldwide. This chart shows projected sales for the entire medical analytics sector, reflecting analyst expectations for investment in science and medicine.
%20sales%20of%20companies%20in%20the%20market%20segment%20-%20Medanalysis&width=1500&height=450&colorIndex=54&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-companies-in-the-market-segment-Medanalysis&v=1772576373384 "Schedule of future (projected) sales of companies in the market segment - Medanalysis")
Future (projected) sales of the market as a whole
Bio-Rad Laboratories supplies instruments and reagents for biomedical research and clinical diagnostics. The company's growth is fueled by global investments in science and healthcare. This chart provides an overview of the overall economic situation, which determines the budgets of research institutes and hospitals—Bio-Rad's key customers.
%20sales%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=55&filename=GURU_Markets_-_Schedule-of-future-predicted-sales-of-the-market-as-a-whole&v=1772576373419 "Schedule of future (predicted) sales of the market as a whole")
Marginality of the company, segment and market as a whole
Company marginality Bio Rad Laboratories
Bio-Rad Laboratories supplies a wide range of instruments and reagents for scientific research and clinical diagnostics. This chart is an indicator of its financial health. It shows what percentage of its high-tech product revenue the company successfully converts into net profit by managing R&D, manufacturing, and global distribution costs.
Market segment marginality - Medanalysis
Bio-Rad Laboratories supplies instruments and reagents for biomedical research and clinical diagnostics. The company's success depends on continuous innovation and efficient manufacturing. This chart compares its operational performance with its competitors, allowing us to assess how effectively its scientific research is translated into commercially successful, highly profitable products.
Market marginality as a whole
Bio-Rad Laboratories supplies instruments and reagents for biomedical research and clinical diagnostics. Their clients include scientific laboratories, hospitals, and biotechnology companies. This overall profitability chart is important because it reflects the level of funding for science and healthcare. Economic growth allows for greater investment in research and diagnostics.
Employees in the company, segment and market as a whole
Number of employees in the company Bio Rad Laboratories
Bio-Rad Laboratories supplies a wide range of instruments and reagents for biomedical research and clinical diagnostics. This chart reflects the scale of its global presence. The growth of its scientific and commercial teams demonstrates its investment in the development of new diagnostic tests and research platforms, supporting scientific progress.
Share of the company's employees Bio Rad Laboratories within the market segment - Medanalysis
Bio-Rad Laboratories creates tools and reagents for biomedical research and clinical diagnostics. This chart shows the percentage of scientists and engineers the company employs in their field. Its human capital is the foundation for developing technologies that advance science and improve healthcare.
Number of employees in the market segment - Medanalysis
Bio-Rad Laboratories supplies instruments and reagents for biomedical research and clinical diagnostics. This chart shows overall employment in the medical analysis sector. Growth reflects increased funding for science and healthcare. For Bio-Rad, this means an expanding customer base and increased demand for their consumables and equipment.
Number of employees in the market as a whole
Bio-Rad Laboratories supplies instruments and reagents for biomedical research and clinical diagnostics. This chart reflects the company's investments in science and healthcare. The growth of its staff, particularly in R&D, indicates the development of new tests and equipment that help scientists and doctors fight diseases and make new discoveries in genetics.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company Bio Rad Laboratories (BIO)
Bio-Rad Laboratories supplies instruments and reagents for biomedical research. This graph shows that the company's value is derived from its scientific potential and patents. The market highly values the intellectual capital invested in each product. The high market capitalization per employee indicates the high added value created by their team.
%20of%20the%20company%20Bio%20Rad%20Laboratories%20(BIO)&width=1500&height=450&colorIndex=63&filename=GURU_Markets_-_Chart-of-market-capitalization-per-employee-in-thousands-of-dollars-of-the-company-Bio-Rad-Laboratories-BIO&v=1772576373826 "Chart of market capitalization per employee (in thousands of dollars) of the company Bio Rad Laboratories (BIO)")
Market capitalization per employee (in thousands of dollars) in the market segment - Medanalysis
Bio-Rad Laboratories supplies instruments and reagents for biomedical research and clinical diagnostics. Like Bio-Techne, it is an R&D-intensive IP business. This metric, compared to the industry average, reflects how highly the market values the company's scientific potential and product portfolio per employee.
%20by%20market%20segment%20-%20Medanalysis&width=1500&height=450&colorIndex=64&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-by-market-segment-Medanalysis&v=1772576373862 "Market capitalization per employee (in thousands of dollars) by market segment - Medanalysis")
Market capitalization per employee (in thousands of dollars) for the overall market
Bio-Rad Laboratories produces instruments and reagents for biomedical research and clinical diagnostics. It's a science-intensive business, where the company's value is determined by its technology and reputation. A high employee rating reflects the significant contribution of each researcher and engineer to the creation of industry-standard products.
%20for%20the%20overall%20market&width=1500&height=450&colorIndex=65&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-for-the-overall-market&v=1772576373900 "Market capitalization per employee (in thousands of dollars) for the overall market")
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company Bio Rad Laboratories (BIO)
Bio-Rad Laboratories supplies a wide range of instruments and reagents for biomedical research and clinical diagnostics. Their business is built on innovation and a broad product catalog. This metric measures the productivity of their R&D and sales staff and how effectively the company translates scientific research into commercially successful diagnostic tests.
%20Chart%20Bio%20Rad%20Laboratories%20(BIO)&width=1500&height=450&colorIndex=66&filename=GURU_Markets_-_Company-Profit-Per-Employee-in-thousands-of-dollars-Chart-Bio-Rad-Laboratories-BIO&v=1772576373951 "Company Profit Per Employee (in thousands of dollars) Chart Bio Rad Laboratories (BIO)")
Profit per employee (in thousands of dollars) in the market segment - Medanalysis
Bio-Rad is a "supplier" for science. They produce "consumables" and instruments for "Life Science" R&D and "Clinical Diagnostics." This graph shows the benchmark for "Medanalysis" (Diagnostics). This industry has high labor margins. It's a "razor and blades" model: the sector sells "consumables" (blades) for research.
%20in%20the%20market%20segment%20-%20Medanalysis&width=1500&height=450&colorIndex=67&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-in-the-market-segment-Medanalysis&v=1772576374006 "Chart of profit per employee (in thousands of dollars) in the market segment - Medanalysis")
Profit per employee (in thousands of dollars) for the market as a whole
Bio-Rad Laboratories (BIO) is a manufacturer and distributor of a wide range of products for biomedical research and clinical diagnostics. They create instruments and reagents for scientists. This chart, showing average profit per employee, provides context. It helps understand how profitable the life sciences sector, which relies on scientists and high-tech manufacturing, is relative to its workforce.
%20for%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=68&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-for-the-market-as-a-whole&v=1772576374043 "Chart of profit per employee (in thousands of dollars) for the market as a whole")
Sales to employees of the company, segment and market as a whole
Sales per company employee Bio Rad Laboratories (BIO)
For Bio-Rad Laboratories, a provider of life sciences and clinical diagnostics products, this chart reflects the value of its technologies. Growing revenue per employee reflects strong demand for the reagents, equipment, and tests used in laboratories and hospitals worldwide.
&width=1500&height=450&colorIndex=69&filename=GURU_Markets_-_Sales-chart-per-company-employee-Bio-Rad-Laboratories-BIO&v=1772576374173 "Sales chart per company employee Bio Rad Laboratories (BIO)")
Sales per employee in the market segment - Medanalysis
Bio-Rad Laboratories supplies instruments and reagents for biomedical research and clinical diagnostics. Success depends on innovation and sales. This metric reflects the average revenue per employee by segment. It helps assess how productive Bio-Rad's team is in monetizing its technologies compared to other companies in the biomedical analysis sector.
Sales per employee for the market as a whole
Bio-Rad Laboratories (BIO) supplies instruments and reagents for biomedical research and clinical diagnostics. This metric reflects how effectively the company monetizes its extensive product portfolio. Growing revenue per employee indicates that their equipment and consumables are in stable demand in laboratories worldwide, and their R&D staff effectively generates revenue.
Short shares by company, segment and market as a whole
Shares shorted by company Bio Rad Laboratories (BIO)
Bio-Rad Laboratories supplies a wide range of instruments and reagents for biomedical research and clinical diagnostics. The company's success depends on global healthcare and research spending. This chart reflects investor bets on potential budget cuts in biotech and academia, as well as intense competition in the diagnostics sector.
&width=1500&height=450&colorIndex=72&filename=GURU_Markets_-_Short-Shares-Chart-for-the-Company-Bio-Rad-Laboratories-BIO&v=1772576374435 "Short Shares Chart for the Company Bio Rad Laboratories (BIO)")
Shares shorted by market segment - Medanalysis
Bio-Rad Laboratories (BIO) supplies a wide range of instruments and reagents for biomedical research and clinical diagnostics. This chart summarizes short positions in the biotech analysis sector. It shows how concerned investors are about R&D budget cuts in the biotech and pharmaceutical industries, which directly impacts demand for the company's products.
Shares shorted by the overall market
Bio-Rad (BIO) supplies equipment for biomedical research and diagnostics. Their clients are biotech and pharmaceutical companies. When Short_All rises, it signals risk aversion. This pessimism leads to a drying up of venture capital funding for biotech companies, forcing them to cut R&D budgets—Bio-Rad's main source of income.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator Bio Rad Laboratories (BIO)
Bio-Rad Laboratories supplies instruments and reagents for biomedical research and diagnostics. The business depends on R&D budgets. A BIO index above 70 may reflect strong demand from the biotech sector. A level below 30 may signal concerns about R&D budget cuts.
&width=1500&height=450&colorIndex=75&filename=GURU_Markets_-_RSI-14-indicator-chart-for-the-companys-stock-Bio-Rad-Laboratories-BIO&v=1772576374550 "RSI 14 indicator chart for the company's stock Bio Rad Laboratories (BIO)")
RSI 14 Market Segment - Medanalysis
Bio-Rad Laboratories is a manufacturer and distributor of a wide range of products for biomedical research and clinical diagnostics. They assist scientists in research and physicians in analysis. This chart measures the overall momentum in the life sciences sector. It helps determine whether the entire segment is oversold following the pandemic or amid cuts in R&D budgets.
RSI 14 for the overall market
Bio-Rad Laboratories supplies instruments and reagents for biomedical research and clinical diagnostics. These are consumables for science and medicine. This business is considered defensive, as research funding and diagnostics continue even during the crisis. This panic chart is significant because, compared to it, Bio-Rad appears to be a stable asset.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast BIO (Bio Rad Laboratories)
Bio-Rad Laboratories is a manufacturer of instruments and consumables for life sciences and clinical diagnostics. Their equipment is used in R&D and hospital laboratories. This chart is a collective 12-month forecast from analysts. It reflects their expectations for pharmaceutical R&D budgets and demand for diagnostic tests (especially after the COVID-19 pandemic subsides).
&width=1500&height=450&colorIndex=78&filename=GURU_Markets_-_A-chart-showing-analyst-consensus-forecasts-for-the-expected-stock-price.-BIO-Bio-Rad-Laboratories&v=1772576374802 "A chart showing analyst consensus forecasts for the expected stock price. BIO (Bio Rad Laboratories)")
The difference between the consensus estimate and the actual stock price BIO (Bio Rad Laboratories)
Bio-Rad Laboratories (BIO) is a manufacturer of instruments and reagents for biomedical research and clinical diagnostics. Their products help scientists and physicians. This chart shows the company's life sciences valuation. It measures the gap between the price and the consensus target, reflecting the potential analysts see in their diagnostics business and their stake in Sartorius.
&width=1500&height=450&colorIndex=79&filename=GURU_Markets_-_A-chart-showing-the-difference-between-the-consensus-forecast-and-the-actual-stock-price.-BIO-Bio-Rad-Laboratories&v=1772576374898 "A chart showing the difference between the consensus forecast and the actual stock price. BIO (Bio Rad Laboratories)")
Analyst consensus forecast for stock prices by market segment - Medanalysis
Bio-Rad Laboratories is a manufacturer of instruments and reagents for biotech research and clinical diagnostics. This chart shows analysts' overall expectations for the medical analysis sector. It reflects whether experts believe R&D spending in the pharmaceutical industry will increase or whether they expect a decline after the pandemic boom.
Analysts' consensus forecast for the overall market share price
Bio-Rad Laboratories is an R&D workhorse. They produce instruments and consumables for life sciences and clinical diagnostics. Market expectations, as shown in this graph, impact their life science segment. If the market is pessimistic, biotech companies (their clients) receive less money and cut R&D budgets.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index Bio Rad Laboratories
Bio-Rad Laboratories is a pillar of the life sciences industry. They operate in two segments: clinical diagnostics (hospital tests) and life science (instruments and reagents for R&D laboratories). This chart reflects their diversified stability. It measures the consistent demand for hospital tests and global biotech spending on R&D.
AKIMA Market Segment Index - Medanalysis
Bio-Rad is a pillar of the life sciences industry; the company (like Agilent) supplies laboratory equipment and consumables for R&D (Life Science) and Clinical Diagnostics (Diagnostics). This composite metric evaluates companies. The graph shows the sector average. This benchmark: how does Bio-Rad's balanced (R&D + Diagnostics) and stable model differentiate it from the average competitor?
The AKIM Index for the overall market
Bio-Rad is the pickaxe and shovels of science. The company supplies reagents, instruments, and software for life science (research) and clinical diagnostics. This chart, reflecting the market average, is a backdrop. It helps assess how this defense business, dependent on pharmaceutical R&D budgets, compares to the overall macroeconomic fluctuations reflected by this indicator.
